Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Uranium and arsenic unregulated water issues on Navajo lands.

Ingram JC, Jones L, Credo J, Rock T.

J Vac Sci Technol A. 2020 May;38(3):031003. doi: 10.1116/1.5142283. Epub 2020 Mar 20.

2.

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses.

Wang G, Kang X, Chen KS, Jehng T, Jones L, Chen J, Huang XF, Chen SY.

Nat Commun. 2020 Mar 13;11(1):1395. doi: 10.1038/s41467-020-15229-5.

3.

Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon Cancer.

Brewer KC, Peacock NR, Ferrans CE, Campbell RT, Polite B, Carnahan L, Jones LA, Rauscher GH.

J Womens Health (Larchmt). 2020 Feb 25. doi: 10.1089/jwh.2019.8163. [Epub ahead of print]

PMID:
32096681
4.

Empowering patients in chronic care to improve diabetes distress and glycaemic control: Protocol for a hybrid implementation-effectiveness clinical trial.

Woodard L, Kamdar N, Hundt N, Gordon HS, Hertz B, Amspoker AB, Kiefer L, Mehta P, Odom E, Rajan S, Stone E, Jones L, Naik AD.

Endocrinol Diabetes Metab. 2019 Nov 18;3(1):e00099. doi: 10.1002/edm2.99. eCollection 2020 Jan.

5.

Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting.

Carnahan LR, Jones L, Brewer KC, Watts EA, Peterson CE, Ferrans CE, Cipriano-Steffens T, Polite B, Maker AV, Chowdhery R, Molina Y, Rauscher GH.

J Cancer Educ. 2019 Dec 14. doi: 10.1007/s13187-019-01666-4. [Epub ahead of print]

PMID:
31838729
6.

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention.

Chen J, Liu H, Jehng T, Li Y, Chen Z, Lee KD, Shen HT, Jones L, Huang XF, Chen SY.

Cancers (Basel). 2019 Dec 1;11(12). pii: E1909. doi: 10.3390/cancers11121909.

7.

Microclimate and Larval Habitat Density Predict Adult Aedes albopictus Abundance in Urban Areas.

Evans MV, Hintz CW, Jones L, Shiau J, Solano N, Drake JM, Murdock CC.

Am J Trop Med Hyg. 2019 Aug;101(2):362-370. doi: 10.4269/ajtmh.19-0220.

8.

A safe and potent anti-CD19 CAR T cell therapy.

Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, Guo X, Liu H, Ding N, Zhang T, Duan P, Lin Y, Zheng W, Wang X, Lin N, Tu M, Xie Y, Zhang C, Liu W, Deng L, Gao S, Ping L, Wang X, Zhou N, Zhang J, Wang Y, Lin S, Mamuti M, Yu X, Fang L, Wang S, Song H, Wang G, Jones L, Zhu J, Chen SY.

Nat Med. 2019 Jun;25(6):947-953. doi: 10.1038/s41591-019-0421-7. Epub 2019 Apr 22.

PMID:
31011207
9.

IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaaq1427. doi: 10.1126/scitranslmed.aaq1427.

10.

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.

Mancini A, Xavier-Magalhães A, Woods WS, Nguyen KT, Amen AM, Hayes JL, Fellmann C, Gapinske M, McKinney AM, Hong C, Jones LE, Walsh KM, Bell RJA, Doudna JA, Costa BM, Song JS, Perez-Pinera P, Costello JF.

Cancer Cell. 2018 Sep 10;34(3):513-528.e8. doi: 10.1016/j.ccell.2018.08.003.

11.

Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.

Woodard LD, Adepoju OE, Amspoker AB, Virani SS, Ramsey DJ, Petersen LA, Jones LA, Kiefer L, Mehta P, Naik AD.

J Gen Intern Med. 2018 Aug;33(8):1276-1282. doi: 10.1007/s11606-018-4386-x. Epub 2018 Apr 2.

12.

Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.

Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper RO.

Cancer Res. 2018 Jun 1;78(11):2966-2977. doi: 10.1158/0008-5472.CAN-17-2269. Epub 2018 Mar 15.

13.

Hospital-Onset Staphylococcus aureus Bacteremia Is A Better Measure Than MRSA Bacteremia for Assessing Infection Prevention: Evaluation of 50 US Hospitals.

Fakih MG, Battjes R, Sturm L, Jones L, Groves C, Bufalino A, Hendrich A.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):476-478. doi: 10.1017/ice.2018.13. Epub 2018 Feb 12.

PMID:
29429428
14.

Efficacy of intracellular immune checkpoint-silenced DC vaccine.

Wang D, Huang XF, Hong B, Song XT, Hu L, Jiang M, Zhang B, Ning H, Li Y, Xu C, Lou X, Li B, Yu Z, Hu J, Chen J, Yang F, Gao H, Ding G, Liao L, Rollins L, Jones L, Chen SY, Chen H.

JCI Insight. 2018 Feb 8;3(3). pii: 98368. doi: 10.1172/jci.insight.98368. eCollection 2018 Feb 8.

15.

Qualitative findings on building a partnered approach to implementation of a group-based diabetes intervention in VA primary care.

Arney J, Thurman K, Jones L, Kiefer L, Hundt NE, Naik AD, Woodard LD.

BMJ Open. 2018 Jan 21;8(1):e018093. doi: 10.1136/bmjopen-2017-018093.

16.

Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors.

Bellini S, Fleming KE, De M, McCauley JP, Petroccione MA, D'Brant LY, Tkachenko A, Kwon S, Jones LA, Scimemi A.

J Neurosci. 2018 Jan 24;38(4):937-961. doi: 10.1523/JNEUROSCI.1906-17.2017. Epub 2017 Dec 11.

17.

Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.

Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH.

Ann Epidemiol. 2017 Nov;27(11):731-738.e1. doi: 10.1016/j.annepidem.2017.10.006. Epub 2017 Oct 13.

18.

Photoresponsive azo-combretastatin A-4 analogues.

Rastogi SK, Zhao Z, Barrett SL, Shelton SD, Zafferani M, Anderson HE, Blumenthal MO, Jones LR, Wang L, Li X, Streu CN, Du L, Brittain WJ.

Eur J Med Chem. 2018 Jan 1;143:1-7. doi: 10.1016/j.ejmech.2017.11.012. Epub 2017 Nov 10.

PMID:
29172077
19.

Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon DA, Costello JF.

Neuro Oncol. 2018 Apr 9;20(5):632-641. doi: 10.1093/neuonc/nox205.

20.

Corrigendum: Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington's disease.

Bragg RM, Coffey SR, Weston RM, Ament SA, Cantle JP, Minnig S, Funk CC, Shuttleworth DD, Woods EL, Sullivan BR, Jones L, Glickenhaus A, Anderson JS, Anderson MD, Dunnett SB, Wheeler VC, MacDonald ME, Brooks SP, Price ND, Carroll JB.

Sci Rep. 2017 Mar 28;7:44960. doi: 10.1038/srep44960. No abstract available.

Supplemental Content

Loading ...
Support Center